4.6 Article

Phenotypic CD8+ T Cell Diversification Occurs before, during, and after the First T Cell Division

期刊

JOURNAL OF IMMUNOLOGY
卷 191, 期 4, 页码 1578-1585

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1300424

关键词

-

资金

  1. Institut Pasteur
  2. INSERM
  3. Fondation pour la Recherche Medicale
  4. European Research Council

向作者/读者索取更多资源

Effector T cell responses rely on a phenotypically and functionally heterogeneous population of cells. Whether this diversity is programmed before clonal expansion or in later phases as a result of stochastic events or asymmetric cell division is not fully understood. In this study, we first took advantage of a sensitive in vitro assay to analyze the composition of single CD8(+) T cell progenies. Heterogeneity was predominantly observed between progenies of distinct clones, but could also be detected within individual progenies. Furthermore, by physically isolating daughter cells of the first T cell division, we showed that differences in paired daughter cell progenies contributed to intraclonal diversification. Finally, we developed an in vivo limiting dilution assay to compare individual T cell progenies following immunization. We provided evidence for simultaneous intraclonal and interclonal diversification in vivo. Our results support the idea that T cell diversification is a continuous process, initiated before clonal expansion and amplified during the first and subsequent cell divisions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Immune response profiling of patients with spondyloarthritis reveals signalling networks mediating TNF-blocker function in vivo

Silvia Menegatti, Vincent Guillemot, Eleonora Latis, Hanane Yahia-Cherbal, Daniela Mittermueller, Vincent Rouilly, Elena Mascia, Nicolas Rosine, Surya Koturan, Gael A. Millot, Claire Leloup, Darragh Duffy, Aude Gleizes, Salima Hacein-Bey-Abina, Jeremie Sellam, Francis Berenbaum, Corinne Miceli-Richard, Maxime Dougados, Elisabetta Bianchi, Lars Rogge

Summary: Anti-TNF therapy induces significant changes in patients' innate immune responses, with selective action and minor effects on Th1/Th17 immunity. Immune response profiling provides new insights into the biology of TNF-blocker action and identifies signaling pathways associated with therapeutic responses to biological therapies.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Multidisciplinary Sciences

Imaging the mechanisms of anti-CD20 therapy in vivo uncovers spatiotemporal bottlenecks in antibody-dependent phagocytosis

Capucine L. Grandjean, Zacarias Garcia, Fabrice Lemaitre, Beatrice Breart, Philippe Bousso

Summary: It was found that macrophages in the bone marrow are the main way to eliminate tumors, but they can only act on neighboring tumors and have a limited active time.

SCIENCE ADVANCES (2021)

Article Biochemistry & Molecular Biology

Functional heterogeneity of cytotoxic T cells and tumor resistance to cytotoxic hits limit anti-tumor activity in vivo

Roxana Khazen, Marine Cazaux, Fabrice Lemaitre, Beatrice Corre, Zacarias Garcia, Philippe Bousso

Summary: The majority of CTL interactions with tumor cells either in vitro or in vivo result in sublethal hits, which are associated with reversible calcium elevation and membrane damage in the target cells. In the therapeutic context of anti-CD19 CAR T cells, most interactions with tumor cells do not lead to lethal hit delivery. Differences in CTL lytic potential and tumor cell resistance to cytotoxic hits are two important barriers for effective anti-tumor responses in vivo.

EMBO JOURNAL (2021)

Article Immunology

A cross-talk between CAR T cell subsets and the tumor microenvironment is essential for sustained cytotoxic activity

Morgane Boulch, Marine Cazaux, Yann Loe-Mie, Ronan Thibaut, Beatrice Corre, Fabrice Lemaitre, Capucine L. Grandjean, Zacarias Garcia, Philippe Bousso

Summary: Chimeric antigen receptor (CAR) T cell therapy relies on interactions with the tumor microenvironment (TME) for optimal activity, with IFN-gamma playing a crucial role in enhancing host immune response and sustaining CAR T cell cytotoxicity. CAR T cell-derived IFN-gamma facilitates host interleukin-12 production to support host immune and CAR T cell responses, highlighting the importance of cytokine-mediated cross-talk for effective CAR T cell therapy.

SCIENCE IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Quorum sensing governs collective dendritic cell activation in vivo

Margot Bardou, Jeremy Postat, Clemence Loaec, Fabrice Lemaitre, Gustave Ronteix, Zacarias Garcia, Philippe Bousso

Summary: Dendritic cell activation by viral RNA sensors is crucial for antiviral immunity, with type I interferon signaling playing a key role. Research shows that a quorum of type I interferon-producing cells is needed for optimal DC activation, with this collective behavior favored by the requirement for prolonged cytokine exposure. Collective DC activation is essential for the development of innate and adaptive immunity in lymph nodes, highlighting the role of collective processes in governing immune responses.

EMBO JOURNAL (2021)

Article Cell Biology

The WASp L272P gain-of-function mutation alters dendritic cell coordination of actin dynamics for migration and adhesion

Mariana M. S. Oliveira, Shin-Yu Kung, Helene D. Moreau, Mathieu Maurin, Julien Record, Doriane Sanseau, Susanne Nylen, Ana-Maria Lennon-Dumenil, Lisa S. Westerberg

Summary: The study found that DCs lacking WASp or carrying the WASp L272P mutation exhibit different characteristics in migration and cell morphology. Compared to wild-type DCs, they show increased migration speed or higher speed fluctuations, but still exhibit differences in location within lymph nodes and cell structure.

JOURNAL OF LEUKOCYTE BIOLOGY (2022)

Review Rheumatology

Is There a Place for Chimeric Antigen Receptor-T Cells in the Treatment of Chronic Autoimmune Rheumatic Diseases?

Cindy Orvain, Morgane Boulch, Philippe Bousso, Yannick Allanore, Jerome Avouac

Summary: CAR-T cell therapy targets tumor antigens with high specificity, demonstrating efficacy in managing B cell malignancies. The technology has potential applications in autoimmune rheumatic diseases, with ongoing research exploring its use and impact in this area.

ARTHRITIS & RHEUMATOLOGY (2021)

Review Cell Biology

Barotaxis: How cells live and move under pressure

Ana-Maria Lennon-Dumenil, Helene D. Moreau

Summary: Cell migration plays a crucial role in physiological functions, being guided by both chemical and physical cues. Besides chemokines, the physical properties of tissues like hydraulic resistance also influence cell migration and may be involved in immune and cancer cell processes.

CURRENT OPINION IN CELL BIOLOGY (2021)

Article Immunology

Epithelial colonization by gut dendritic cells promotes their functional diversification

Claudia A. Rivera, Violaine Randrian, Wilfrid Richer, Yohan Gerber-Ferder, Maria-Graciela Delgado, Aleksandra S. Chikina, Annika Frede, Chiara Sorini, Mathieu Maurin, Hana Kammoun-Chaari, Sara M. Parigi, Christel Goudot, Mar Cabeza-Cabrerizo, Sylvain Baulande, Sonia Lameiras, Pierre Guermonprez, Caetano Reis e Sousa, Marc Lecuit, Helene D. Moreau, Julie Helft, Danijela Matic Vignjevic, Eduardo J. Villablanca, Ana-Maria Lennon-Dumenil

Summary: There are two pools of cDC2s in the small intestine, originating from common pre-DC precursors, and their phenotypes are influenced by food-derived retinoic acid.

IMMUNITY (2022)

Review Immunology

Diving into the mechanism of action of tumor immunotherapies with intravital imaging*

Philippe Bousso

Summary: Tumor immunotherapies like tumor-targeting monoclonal antibodies, immune checkpoint blockers, and CAR T cells have shown clinical successes and raised hopes, emphasizing the need for better understanding of their precise mechanisms in the patient body to optimize therapeutic efficacy. In this context, intravital two-photon imaging provides unique insights into the mode of action of these therapies and helps identify critical bottlenecks in vivo, contributing to the emergence of new concepts in anti-tumor immune responses.

IMMUNOLOGICAL REVIEWS (2022)

Article Multidisciplinary Sciences

High resolution microfluidic assay and probabilistic modeling reveal cooperation between T cells in tumor killing

Gustave Ronteix, Shreyansh Jain, Christelle Angely, Marine Cazaux, Roxana Khazen, Philippe Bousso, Charles N. Baroud

Summary: The cytotoxic T cell responses to cancer vary greatly among individuals. By studying the stochastic modeling of high-throughput T cell behavior and matched tumor spheroid fate data generated by a microfluidics system, the authors show that tumor killing is dependent on T cell cooperativity, which may contribute to the heterogeneity of T cell responses.

NATURE COMMUNICATIONS (2022)

Article Genetics & Heredity

Integrative genetic and immune cell analysis of plasma proteins in healthy donors identifies novel associations involving primary immune deficiency genes

Barthelemy Caron, Etienne Patin, Maxime Rotival, Bruno Charbit, Matthew L. Albert, Lluis Quintana-Murci, Darragh Duffy, Antonio Rausell

Summary: This study evaluated plasma protein levels in a cohort of 400 unrelated healthy individuals of western European ancestry and identified novel genetic and non-genetic factors associated with plasma protein levels.

GENOME MEDICINE (2022)

Review Oncology

Time 2EVOLVE: predicting efficacy of engineered T-cells - how far is the bench from the bedside?

Sonia Guedan, Maik Luu, Delphine Ammar, Paula Barbao, Chiara Bonini, Philippe Bousso, Christian J. Buchholz, Monica Casucci, Biagio De Angelis, Emmanuel Donnadieu, David Espie, Beatrice Greco, Richard Groen, Johannes B. Huppa, Chahrazade Kantari-Mimoun, Bruno Laugel, Mary Mantock, Janet L. Markman, Emma Morris, Concetta Quintarelli, Michael Rade, Kristin Reiche, Alba Rodriguez-Garcia, Juan Roberto Rodriguez-Madoz, Eliana Ruggiero, Maria Themeli, Michael Hudecek, Ibtissam Marchiq

Summary: Immunotherapy with gene engineered CAR and TCR transgenic T-cells is a groundbreaking treatment in cancer medicine, and has the potential to be used in common solid tumors. However, in order to improve and accelerate the selection of lead T-cell products for clinical translation, it is necessary to assess preclinical models and develop new models with higher predictive value.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Immunology

Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability

Valeria Fumagalli, Valentina Venzin, Pietro Di Lucia, Federica Moalli, Xenia Ficht, Gioia Ambrosi, Leonardo Giustini, Francesco Andreata, Marta Grillo, Diletta Magini, Micol Rava, Christin Friedrich, Jason D. Fontenot, Philippe Bousso, Sarah A. Gilmore, Shahzada Khan, Manuel Baca, Eric Vivier, Georg Gasteiger, Mirela Kuka, Luca G. Guidotti, Matteo Iannacone

Summary: Group 1 innate lymphoid cells (ILCs) play a role in controlling T cell-mediated liver immunopathology by limiting local IL-2 concentration.

SCIENCE IMMUNOLOGY (2022)

Article Oncology

Bystander IFN-γ activity promotes widespread and sustained cytokine signaling altering the tumor microenvironment

Ronan Thibaut, Pierre Bost, Idan Milo, Marine Cazaux, Fabrice Lemaitre, Zacarias Garcia, Ido Amit, Beatrice Breart, Clemence Cornuot, Benno Schwikowski, Philippe Bousso

NATURE CANCER (2020)

暂无数据